US Stock MarketDetailed Quotes

HCSG Healthcare Services Group

Watchlist
  • 10.840
  • -0.470-4.16%
Close Feb 14 16:00 ET
  • 10.840
  • 0.0000.00%
Post 20:01 ET
794.48MMarket Cap20.45P/E (TTM)

Healthcare Services Group Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-29.19%30.8M
-26.78%36.2M
46.67%4.31M
118.91%16.25M
-59.19%-25.96M
632.61%43.5M
115.98%49.45M
129.71%2.94M
-17.69%7.42M
45.96%-16.31M
Net income from continuing operations
2.83%39.47M
-49.29%11.92M
377.99%14.03M
-121.66%-1.79M
31.17%15.31M
12.10%38.39M
49.05%23.51M
-1,667.39%-5.05M
21.03%8.25M
3.02%11.67M
Operating gains losses
44.99%1.19M
46.50%482K
193.14%299K
-13.13%225K
40.63%180K
-28.12%818K
67.86%329K
-73.30%102K
-33.07%259K
-26.01%128K
Depreciation and amortization
1.68%14.59M
-4.68%3.6M
16.09%3.77M
-0.14%3.61M
-2.70%3.6M
-6.35%14.34M
0.61%3.78M
-14.36%3.25M
-0.08%3.62M
-10.78%3.7M
Deferred tax
38.92%-2.94M
-116.59%-1.33M
144.10%1.87M
-336,300.00%-3.36M
-381.40%-121K
-198.23%-4.82M
-112.53%-615K
---4.25M
---1K
--43K
Other non cash items
51.13%-564K
----
----
1.49%-265K
-445.00%-69K
50.96%-1.15M
----
----
---269K
--20K
Change In working capital
-58.94%-70.19M
-55.26%9.71M
-67.48%-16.22M
8.14%-14.99M
-22.18%-48.69M
61.34%-44.16M
352.41%21.69M
60.43%-9.69M
35.90%-16.32M
28.48%-39.85M
-Change in receivables
17.10%-61.81M
74.05%-3.9M
-18,014.55%-9.85M
45.96%-21.05M
-30.89%-27.01M
5.27%-74.56M
-310.07%-15.03M
100.34%55K
-10.18%-38.95M
12.04%-20.63M
-Change in inventory
-35.53%1.73M
-58.11%297K
2.92%811K
-26.88%185K
-53.16%438K
-44.65%2.69M
-54.20%709K
-4.25%788K
-80.31%253K
-21.76%935K
-Change in prepaid assets
-94.48%704K
1.86%4.21M
-101.51%-12K
-282.52%-6.84M
-17.81%3.35M
28.33%12.75M
9.99%4.13M
-88.10%796K
91.81%3.75M
265.56%4.08M
-Change in payables and accrued expense
-347.95%-19.49M
-68.84%8.29M
-2.89%-9.44M
-23.85%12.49M
-18.74%-30.82M
121.76%7.86M
420.70%26.59M
27.28%-9.18M
68.62%16.41M
-4.13%-25.96M
-Change in other current liabilities
----
----
----
----
289.29%1.31M
----
----
----
----
119.09%336K
-Change in other working capital
22.05%8.67M
-93.25%291K
339.93%2.8M
-40.30%1.53M
189.90%4.05M
149.97%7.1M
199.15%4.31M
57.95%-1.17M
191.86%2.56M
132.47%1.4M
Cash from discontinued investing activities
Operating cash flow
-29.19%30.8M
-26.78%36.2M
46.67%4.31M
120.44%16.32M
-59.81%-26.03M
632.61%43.5M
115.98%49.45M
129.71%2.94M
-17.91%7.4M
46.03%-16.29M
Investing cash flow
Cash flow from continuing investing activities
283.63%6.05M
1,676.14%21.8M
122.62%288K
-26,283.96%-27.76M
1,676.85%11.72M
-227.64%-3.29M
-373.63%-1.38M
1.01%-1.27M
-98.08%106K
45.96%-743K
Net PPE purchase and sale
-15.89%-6.13M
1.67%-1.41M
26.30%-1.36M
-12.09%-1.19M
-128.02%-2.17M
-9.72%-5.29M
-66.24%-1.43M
-16.75%-1.84M
5.78%-1.06M
24.06%-953K
Net business purchase and sale
---2.75M
--0
--0
--0
---2.75M
--0
--0
--0
--0
--0
Net investment purchase and sale
649.10%14.92M
46,314.00%23.21M
189.95%1.64M
-2,380.52%-26.57M
7,823.33%16.64M
-73.48%1.99M
-91.23%50K
95.52%567K
-82.50%1.17M
3,600.00%210K
Cash from discontinued investing activities
Investing cash flow
283.63%6.05M
1,676.14%21.8M
122.62%288K
-26,283.96%-27.76M
1,676.85%11.72M
-227.64%-3.29M
-373.63%-1.38M
1.01%-1.27M
-98.08%106K
45.96%-743K
Financing cash flow
Cash flow from continuing financing activities
-155.45%-31.05M
-3.85%-26.01M
-710.57%-6.01M
-360.00%-13M
102.26%13.97M
68.78%-12.15M
-56.97%-25.05M
213.63%984K
131.71%5M
208.98%6.91M
Net issuance payments of debt
---25M
-25.00%-25M
-200.00%-5M
-300.00%-10M
50.00%15M
--0
---20M
-66.67%5M
--5M
0.00%10M
Net common stock issuance
55.53%-5.02M
79.98%-1.01M
74.90%-1.01M
---3M
--0
-10,744.34%-11.28M
-17,493.10%-5.04M
-15,546.15%-4.02M
--0
-8,992.00%-2.22M
Cash dividends paid
--0
----
----
----
----
--0
----
----
----
----
Proceeds from stock option exercised by employees
--0
----
----
----
----
--0
----
----
----
----
Net other financing activities
-18.25%-1.03M
--0
--0
--0
-18.39%-1.03M
18.67%-871K
---1K
--0
--0
18.62%-870K
Cash from discontinued financing activities
Financing cash flow
-155.45%-31.05M
-3.85%-26.01M
-710.57%-6.01M
-360.00%-13M
102.26%13.97M
68.78%-12.15M
-56.97%-25.05M
213.63%984K
131.71%5M
208.98%6.91M
Net cash flow
Beginning cash position
106.74%54.33M
-10.14%28.14M
3.09%29.55M
234.20%53.98M
106.74%54.33M
-62.88%26.28M
59.49%31.31M
-9.53%28.66M
-50.90%16.15M
-62.88%26.28M
Current changes in cash
-79.32%5.8M
38.99%31.99M
-153.11%-1.41M
-295.35%-24.44M
96.57%-347K
163.01%28.05M
246.33%23.02M
122.00%2.65M
1,127.01%12.51M
73.28%-10.13M
End cash Position
10.68%60.13M
10.68%60.13M
-10.14%28.14M
3.09%29.55M
234.20%53.98M
106.74%54.33M
106.74%54.33M
59.49%31.31M
-9.53%28.66M
-50.90%16.15M
Free cash flow
-35.77%24.47M
-27.57%34.78M
173.78%2.91M
137.60%15.01M
-63.18%-28.23M
384.76%38.09M
119.99%48.01M
109.29%1.06M
-19.49%6.32M
45.23%-17.3M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
--
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -29.19%30.8M-26.78%36.2M46.67%4.31M118.91%16.25M-59.19%-25.96M632.61%43.5M115.98%49.45M129.71%2.94M-17.69%7.42M45.96%-16.31M
Net income from continuing operations 2.83%39.47M-49.29%11.92M377.99%14.03M-121.66%-1.79M31.17%15.31M12.10%38.39M49.05%23.51M-1,667.39%-5.05M21.03%8.25M3.02%11.67M
Operating gains losses 44.99%1.19M46.50%482K193.14%299K-13.13%225K40.63%180K-28.12%818K67.86%329K-73.30%102K-33.07%259K-26.01%128K
Depreciation and amortization 1.68%14.59M-4.68%3.6M16.09%3.77M-0.14%3.61M-2.70%3.6M-6.35%14.34M0.61%3.78M-14.36%3.25M-0.08%3.62M-10.78%3.7M
Deferred tax 38.92%-2.94M-116.59%-1.33M144.10%1.87M-336,300.00%-3.36M-381.40%-121K-198.23%-4.82M-112.53%-615K---4.25M---1K--43K
Other non cash items 51.13%-564K--------1.49%-265K-445.00%-69K50.96%-1.15M-----------269K--20K
Change In working capital -58.94%-70.19M-55.26%9.71M-67.48%-16.22M8.14%-14.99M-22.18%-48.69M61.34%-44.16M352.41%21.69M60.43%-9.69M35.90%-16.32M28.48%-39.85M
-Change in receivables 17.10%-61.81M74.05%-3.9M-18,014.55%-9.85M45.96%-21.05M-30.89%-27.01M5.27%-74.56M-310.07%-15.03M100.34%55K-10.18%-38.95M12.04%-20.63M
-Change in inventory -35.53%1.73M-58.11%297K2.92%811K-26.88%185K-53.16%438K-44.65%2.69M-54.20%709K-4.25%788K-80.31%253K-21.76%935K
-Change in prepaid assets -94.48%704K1.86%4.21M-101.51%-12K-282.52%-6.84M-17.81%3.35M28.33%12.75M9.99%4.13M-88.10%796K91.81%3.75M265.56%4.08M
-Change in payables and accrued expense -347.95%-19.49M-68.84%8.29M-2.89%-9.44M-23.85%12.49M-18.74%-30.82M121.76%7.86M420.70%26.59M27.28%-9.18M68.62%16.41M-4.13%-25.96M
-Change in other current liabilities ----------------289.29%1.31M----------------119.09%336K
-Change in other working capital 22.05%8.67M-93.25%291K339.93%2.8M-40.30%1.53M189.90%4.05M149.97%7.1M199.15%4.31M57.95%-1.17M191.86%2.56M132.47%1.4M
Cash from discontinued investing activities
Operating cash flow -29.19%30.8M-26.78%36.2M46.67%4.31M120.44%16.32M-59.81%-26.03M632.61%43.5M115.98%49.45M129.71%2.94M-17.91%7.4M46.03%-16.29M
Investing cash flow
Cash flow from continuing investing activities 283.63%6.05M1,676.14%21.8M122.62%288K-26,283.96%-27.76M1,676.85%11.72M-227.64%-3.29M-373.63%-1.38M1.01%-1.27M-98.08%106K45.96%-743K
Net PPE purchase and sale -15.89%-6.13M1.67%-1.41M26.30%-1.36M-12.09%-1.19M-128.02%-2.17M-9.72%-5.29M-66.24%-1.43M-16.75%-1.84M5.78%-1.06M24.06%-953K
Net business purchase and sale ---2.75M--0--0--0---2.75M--0--0--0--0--0
Net investment purchase and sale 649.10%14.92M46,314.00%23.21M189.95%1.64M-2,380.52%-26.57M7,823.33%16.64M-73.48%1.99M-91.23%50K95.52%567K-82.50%1.17M3,600.00%210K
Cash from discontinued investing activities
Investing cash flow 283.63%6.05M1,676.14%21.8M122.62%288K-26,283.96%-27.76M1,676.85%11.72M-227.64%-3.29M-373.63%-1.38M1.01%-1.27M-98.08%106K45.96%-743K
Financing cash flow
Cash flow from continuing financing activities -155.45%-31.05M-3.85%-26.01M-710.57%-6.01M-360.00%-13M102.26%13.97M68.78%-12.15M-56.97%-25.05M213.63%984K131.71%5M208.98%6.91M
Net issuance payments of debt ---25M-25.00%-25M-200.00%-5M-300.00%-10M50.00%15M--0---20M-66.67%5M--5M0.00%10M
Net common stock issuance 55.53%-5.02M79.98%-1.01M74.90%-1.01M---3M--0-10,744.34%-11.28M-17,493.10%-5.04M-15,546.15%-4.02M--0-8,992.00%-2.22M
Cash dividends paid --0------------------0----------------
Proceeds from stock option exercised by employees --0------------------0----------------
Net other financing activities -18.25%-1.03M--0--0--0-18.39%-1.03M18.67%-871K---1K--0--018.62%-870K
Cash from discontinued financing activities
Financing cash flow -155.45%-31.05M-3.85%-26.01M-710.57%-6.01M-360.00%-13M102.26%13.97M68.78%-12.15M-56.97%-25.05M213.63%984K131.71%5M208.98%6.91M
Net cash flow
Beginning cash position 106.74%54.33M-10.14%28.14M3.09%29.55M234.20%53.98M106.74%54.33M-62.88%26.28M59.49%31.31M-9.53%28.66M-50.90%16.15M-62.88%26.28M
Current changes in cash -79.32%5.8M38.99%31.99M-153.11%-1.41M-295.35%-24.44M96.57%-347K163.01%28.05M246.33%23.02M122.00%2.65M1,127.01%12.51M73.28%-10.13M
End cash Position 10.68%60.13M10.68%60.13M-10.14%28.14M3.09%29.55M234.20%53.98M106.74%54.33M106.74%54.33M59.49%31.31M-9.53%28.66M-50.90%16.15M
Free cash flow -35.77%24.47M-27.57%34.78M173.78%2.91M137.60%15.01M-63.18%-28.23M384.76%38.09M119.99%48.01M109.29%1.06M-19.49%6.32M45.23%-17.3M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes------------------

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
XINGANJIANG
873167
+30.00%
INNOVATIVE DATA
835305
+29.98%
CHENGUANG MEDICAL
430300
+29.96%
4
Hangzhou Gaoxin Materials Technology
300478
+20.04%
5
Beijing Philisense Technology
300287
+20.03%
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.
Discussing
Tesla's earnings caused fluctuations, what's your market outlook？
Tesla's Q4 2024 revenue was $25.71 billion, up 2% year-on-year but below expectations. Can Tesla's stock price keep rising in 2025 with Trum Show More
TSLA earnings preview: Grab rewards by guessing the opening price!